Rahul Kumar

Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Jeff M. Michalski, Anna J. Janss, L. Gilbert Vezina et al. · Journal of Clinical Oncology · 2021 · 203 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Anthony P. Y. Liu, Kyle Smith, Rahul Kumar et al. · Cancer Cell · 2021 · 179 citations · Full text

Medicine, Oncology, Pathology +16

Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma

Sarah Leary, Roger J. Packer, Yimei Li et al. · JAMA Oncology · 2021 · 158 citations · Full text

Medicine, Oncology, Pediatrics +17

Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study

Raja B. Khan, Zoltán Patay, Paul Klimo et al. · Neuro-Oncology · 2021 · 97 citations · Full text

Medicine, Pediatrics, Surgery +13

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma

Rahul Kumar, Kyle Smith, Maximilian Deng et al. · Journal of Clinical Oncology · 2021 · 86 citations · Full text

Medicine, Oncology, Radiation Oncology +17